Clinical evaluation and staging of patients who have lung cancer.
This article updates the performance characteristics of the most commonly used diagnostic and staging modalities in the evaluation of a patient who has lung cancer. Recent data with newer modalities, like positron emission tomography, are reviewed, and their role in this evaluation is discussed.
Hensing
Thomas A
TA
Feinberg School of Medicine, Northwestern University, 2650 Ridge Avenue, Evanston, IL 60201, USA. thensing@enh.org
D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000175:diagnosis / Q000473:pathology; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000473:pathology*; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography
D019788:Fluorodeoxyglucose F18